Medical Net, Inc.
3645.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥6 | ¥5 | ¥5 | ¥4 |
| % Growth | 15.6% | 16.7% | 20.2% | – |
| Cost of Goods Sold | ¥4 | ¥3 | ¥3 | ¥2 |
| Gross Profit | ¥2 | ¥2 | ¥2 | ¥1 |
| % Margin | 32.3% | 35.1% | 39.6% | 39% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥2 | ¥2 | ¥1 | ¥1 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | -¥0 | ¥0 | -¥0 |
| Operating Expenses | ¥2 | ¥2 | ¥1 | ¥1 |
| Operating Income | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | 1.6% | 5.7% | 8.4% | 11.9% |
| Other Income/Exp. Net | -¥0 | -¥0 | -¥0 | ¥0 |
| Pre-Tax Income | ¥0 | ¥0 | ¥0 | ¥1 |
| Tax Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Net Income | -¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | -1.1% | 0.1% | 2.6% | 10.1% |
| EPS | -7.64 | 0.66 | 12.97 | 43.44 |
| % Growth | -1,257.6% | -94.9% | -70.1% | – |
| EPS Diluted | -7.64 | 0.66 | 12.97 | 43.44 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥0 | ¥0 | ¥0 | ¥1 |
| % Margin | 1.9% | 4.1% | 7% | 15.2% |